Physician profile
Frederick Tinkham Mcfall
NPI 1427177088
$284.97
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.41 · 2020: $35.26 · 2021: $83.29 · 2022: $67.53 · 2023: $13.12 · 2024: $45.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $48.41 | 2021-2022 | |
| Amgen INC. | $37.01 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $29.46 | 2024 | |
| Genzyme Corporation | $24.04 | 2021 | |
| Clovis Oncology, INC. | $23.65 | 2019 | |
| Morphosys, US INC. | $23.15 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $19.69 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.06 | 2021 | |
| Celgene Corporation | $16.76 | 2019 | |
| Acceleron Pharma, INC. | $16.72 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.90 | 2024 | |
| Merck Sharp & Dohme LLC | $13.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Mcfall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.